Prachi Shah
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
M.D.
Also affiliated: Arkansas Children's Hospital (2026)
Research Areas
Biography and Research Information
OverviewAI-generated summary
Prachi Shah's research has focused on the use of sirolimus to treat non-immune hydrops in preterm neonates, particularly when the condition is associated with vascular and lymphatic anomalies. This work utilizes imaging to assess treatment response, drawing from data collected within a Level IV Neonatal Intensive Care Unit. The study's findings were published in 2026, indicating recent engagement with this research area.
Metrics
- h-index: 2
- Publications: 5
- Citations: 57
Positions
-
M.D. publications 2026University of Arkansas for Medical Sciences Institution web page
Selected Publications
-
Sirolimus for non-immune hydrops due to vascular and lymphatic anomalies in preterm neonates: an imaging-anchored response phenotype from a level IV NICU (2026)
-
HTRS2025.P1.27 Prevalence Vitamin D deficiency and risk factors for poor bone health in persons with Hemophilia A and B in Arkansas – A retrospective single institution study (2025)
Collaboration Network
Top Collaborators
- Sirolimus for non-immune hydrops due to vascular and lymphatic anomalies in preterm neonates: an imaging-anchored response phenotype from a level IV NICU
- Sirolimus for non-immune hydrops due to vascular and lymphatic anomalies in preterm neonates: an imaging-anchored response phenotype from a level IV NICU
- Sirolimus for non-immune hydrops due to vascular and lymphatic anomalies in preterm neonates: an imaging-anchored response phenotype from a level IV NICU
- Sirolimus for non-immune hydrops due to vascular and lymphatic anomalies in preterm neonates: an imaging-anchored response phenotype from a level IV NICU
- Sirolimus for non-immune hydrops due to vascular and lymphatic anomalies in preterm neonates: an imaging-anchored response phenotype from a level IV NICU
- Sirolimus for non-immune hydrops due to vascular and lymphatic anomalies in preterm neonates: an imaging-anchored response phenotype from a level IV NICU
- Sirolimus for non-immune hydrops due to vascular and lymphatic anomalies in preterm neonates: an imaging-anchored response phenotype from a level IV NICU
- Sirolimus for non-immune hydrops due to vascular and lymphatic anomalies in preterm neonates: an imaging-anchored response phenotype from a level IV NICU
- Sirolimus for non-immune hydrops due to vascular and lymphatic anomalies in preterm neonates: an imaging-anchored response phenotype from a level IV NICU
Similar Researchers
Based on overlapping research topics